Topiramate for the treatment of juvenile myoclonic epilepsy

Arquivos de Neuro-Psiquiatria

Volumn 63, Issue 3 B, 2005, Pages 733-737

  Da Silva Sousa, Patrícia ^a   De Araújo Filho, Gerardo Maria ^a   Garzon, Eliana ^a   Sakamoto, Américo C ^a   Yacubian, Elza Márcia T ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Juvenile myoclonic epilepsy; Topiramate; Treatment

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

ABDOMINAL PAIN; ADULT; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; DRY EYE; ERYTHEMA; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HUMOR; LANGUAGE DISABILITY; MALE; MEMORY DISORDER; MYOCLONUS EPILEPSY; PARESTHESIA; PATIENT COMPLIANCE; SEIZURE; SIDE EFFECT; SOMNOLENCE; THIRST; TONIC CLONIC SEIZURE; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION; XEROSTOMIA;

EID: 27144544222     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2005000500001     Document Type: Article

References (13)

1. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia. 1982;23:693-720.
2. Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984;34:285-294.
3. Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy. Epilepsia 1989;30(Suppl4):S19-S23.
4. Rosenfeld WE. Topiramate, a broad-spectrum agent, in patients with juvenile myoclonic epilepsy. Epilepsia 1999;40(Suppl 2):226.
5. Prasad A, Kuzniecky R, Knowlton RC, et al. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol 2003;60:1110-1103.
6. Levisohn PM, Holland KD, Hulihan JF, Fisher AC. Topiramate versus valproate in patients with juvenile myoclonic epilepsy. Epilepsia 2003;44(Suppl 9):S267-S268.
7. Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin DO, Legido A. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord 2004;6:267-270.
8. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999;52:1330-1337.
9. Barrera MN. Characteristics and indications of topiramate. Rev Neurol 2002;35:88-95.
10. Kellett MW, Smith DF, Stockton PPA, Chadwick DW. Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry 1999;66:759-763.
11. Ramsay RE, Rowan AJ, Spitz M, et al. A double-blind study of topiramate (TPM) monotherapy in older patients with partial-onset seizures. Epilepsia 2004;45(Suppl 7):S127.
12. Edwards JC, Privitera MD, Neto W, Wu SC. Topiramate vs. carbamazepine and valproate in newly diagnosed epilepsy: effectiveness according to seizure type. Epilepsia 2004;45(Suppl 7):S139.
13. Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia. 2001;42:1255-1260.